Brief: Aethlon Medical Announces Contract With Namsa To Advance Hemopurifier Clinical Programs In Cancer
Jan 30 (Reuters) - Aethlon Medical Inc AEMD.O :
* AETHLON MEDICAL ANNOUNCES CONTRACT WITH NAMSA TO ADVANCE
HEMOPURIFIER CLINICAL PROGRAMS IN CANCER
* AETHLON MEDICAL INC - NAMSA WILL MANAGE CO'S STUDY OF
HEMOPURIFIER FOR PATIENTS IN UNITED STATES AND AUSTRALIA WITH
VARIOUS TYPES OF CANCER TUMORS
* AETHLON MEDICAL INC - ANTICIPATED INITIAL CLINICAL TRIALS
WILL
BEGIN IN AUSTRALIA
Source text for Eikon: ID:nPn648t2Sa
Further company coverage: AEMD.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Aethlon Medical
See all newsU.S. STOCKS ON THE MOVE -Nebius, Securitize, Viant Technology
U.S. STOCKS ON THE MOVE -GlobalFoundries, Lucid, Phillips 66
U.S. STOCKS ON THE MOVE-Generac, Jefferies, Applied Digital
U.S. STOCKS ON THE MOVE-Generac, Jefferies, Aethlon Medical
Aethlon Medical skyrockets after merger with North Immunology